WELLINGTON MANAGEMENT GROUP LLP - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 275 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$115,866,512
-16.1%
3,033,949
-9.6%
0.02%
-11.5%
Q2 2023$138,104,752
-49.5%
3,357,762
-29.5%
0.03%
-51.9%
Q1 2023$273,572,429
-12.5%
4,765,240
-14.5%
0.05%
-14.3%
Q4 2022$312,535,638
+41.6%
5,574,026
+7.0%
0.06%
+34.0%
Q3 2022$220,679,000
-38.9%
5,209,623
-22.1%
0.05%
-35.6%
Q2 2022$361,167,000
-24.1%
6,684,563
-9.7%
0.07%
-9.9%
Q1 2022$475,721,000
-26.9%
7,403,074
-23.8%
0.08%
-22.1%
Q4 2021$651,170,000
-1.1%
9,720,376
+1.1%
0.10%
-7.1%
Q3 2021$658,184,000
+4.3%
9,611,342
+3.9%
0.11%
+6.7%
Q2 2021$631,018,000
-0.7%
9,247,042
+0.6%
0.10%
-6.2%
Q1 2021$635,221,000
+5.6%
9,194,123
-0.7%
0.11%
+0.9%
Q4 2020$601,379,000
+62.8%
9,263,394
+18.4%
0.11%
+46.1%
Q3 2020$369,314,000
+44.6%
7,821,144
+43.9%
0.08%
+33.3%
Q2 2020$255,332,000
+9.9%
5,433,759
+4.5%
0.06%
-6.6%
Q1 2020$232,326,000
-22.8%
5,200,940
+0.7%
0.06%
-3.2%
Q4 2019$301,118,000
-0.6%
5,166,760
+2.4%
0.06%
-7.4%
Q3 2019$303,071,000
+16.1%
5,045,308
+7.9%
0.07%
+17.2%
Q2 2019$261,089,000
+5.1%
4,674,837
+4.9%
0.06%
+3.6%
Q1 2019$248,385,000
+27.8%
4,457,745
+3.5%
0.06%
+14.3%
Q4 2018$194,295,000
-23.7%
4,308,105
+11.5%
0.05%
-9.3%
Q3 2018$254,545,000
+60.8%
3,864,349
+57.3%
0.05%
+54.3%
Q2 2018$158,275,000
+34.4%
2,457,299
+15.4%
0.04%
+29.6%
Q1 2018$117,806,000
+28.2%
2,128,764
+10.8%
0.03%
+35.0%
Q4 2017$91,925,000
+40.5%
1,920,717
+48.2%
0.02%
+33.3%
Q3 2017$65,436,000
+94.4%
1,296,266
+109.9%
0.02%
+87.5%
Q2 2017$33,658,000
+52.5%
617,468
+17.9%
0.01%
+60.0%
Q1 2017$22,073,000
-2.3%
523,921
+98.9%
0.01%
-16.7%
Q4 2016$22,599,000
+170.3%
263,427
+112.3%
0.01%
+200.0%
Q2 2015$8,361,000
+14.8%
124,106
+5.1%
0.00%0.0%
Q1 2015$7,283,000
+23.9%
118,136
+9.0%
0.00%0.0%
Q4 2014$5,880,000
-71.2%
108,426
-73.6%
0.00%
-66.7%
Q3 2014$20,394,000
+304.7%
410,845
+283.7%
0.01%
+500.0%
Q2 2014$5,039,000
+9.0%
107,080
+6.5%
0.00%0.0%
Q1 2014$4,624,000
-6.2%
100,550
-2.7%
0.00%0.0%
Q4 2013$4,928,000
+17.3%
103,300
-1.1%
0.00%0.0%
Q3 2013$4,202,000
+5.1%
104,400
-4.3%
0.00%0.0%
Q2 2013$3,997,000109,1000.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q4 2022
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders